Trial Profile
A Retrospective, Observational Study Investigating the Efficacy and Tolerance of Pomalidomide Plus Dexamethasone (PD) as Salvage Regimen in Heavily Pretreated Patients with Relapsed and Refractory Multiple Myeloma (rrMM)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2018
Price :
$35
*
At a glance
- Drugs Pomalidomide (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 24 Jul 2018 New trial record
- 17 Jun 2018 Results presented at the 23rd Congress of the European Haematology Association.